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KEY POINTS
 Patients with inflammatory bowel disease (IBD) have an increased risk of colorectal cancer
(CRC).
 Studies suggest that the current standard of colonoscopy surveillance with random
biopsies to detect dysplasia in IBD patients is inadequate.
 With the use of current knowledge, technology and techniques most dysplasia in IBD
patients is visible during colonoscopy.
 Data and guidelines now support the use of chromoendoscopy with targeted biopsy in the
detection of dysplasia and/or colorectal cancer in patients with colitic IBD.INTRODUCTION
The role of endoscopy in the management of patients with inflammatory bowel dis-
ease (IBD) is well established. However, recent data have shown significant limitations
in the effectiveness of the use of colonoscopy to prevent colorectal cancer (CRC) in
patients with IBD colitis. The current standard using random biopsy appeared to be
largely ineffective in detecting the nonpolypoid colorectal neoplasms (NP-CRN).
Data using chromoendoscopy with targeted biopsy, however, showed a significant
improvement when used to detect dysplasia, the best predictor of colorectal cancer
risk. The purpose of this monograph is to provide the medical profession with a useful
and organized series of images showing the superficial elevated, flat, and depressed
colorectal neoplasms and their appearance after the application of the technique of
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Soetikno et al484Fig. 1. Endoscopic view of nonpolypoid colorectal neoplasm.
Fig. 2.Current surveillance against CRC is associated with a high risk of interval cancer. In a
study of 55,000 Medicare patients diagnosed with CRC, patients with IBD were 3 times
more likely to have had a recent colonoscopy than patients without IBD. A significant frac-
tion (15%) of the IBD patients who were diagnosed with CRC had undergone surveillance
colonoscopy in the prior 3 years. Note that many of these cancers were advanced. These
data indicate that the standard method used during surveillance colonoscopy, namely the
random biopsy technique, is inadequate.1
Atlas of Flat Lesions in IBD 485Fig. 3. Random biopsy without interpreting what is being viewed is not effective. This
example shows that random biopsy of the colon to detect and diagnose dysplasia has a
high miss rate.2 In this patient, random biopsies were taken from the circled areas, as
shown by the blood. Unfortunately the neoplasia (encircled by the dashed line) was not bio-
psied. Note that the high-definition adult colonoscope was used, and the lesion was not
detected. High definition increases the resolution of the image. For example, high definition
captures at least 720 pixels from top to bottom (with most capturing 1080 pixels), whereas
standard definition captures 480 pixels. What is needed, however, is not only increased
resolution, but also improved contrast between dysplastic and nondysplastic mucosa. If
the dysplasia can be highlighted or colored distinctly, its detection and diagnosis may
be easier.Fig. 4. An example of an interval cancer in a patient with ulcerative colitis. This patient was
referred to the authors 1 year after image (A) was taken. He presented for staging endo-
scopic ultrasonography after a repeat surveillance showed an ulcerated mass lesion (B).
The lesion had become an advanced cancer. He underwent a total proctocolectomy. T2,
N2 poorly differentiated carcinoma was found.
Soetikno et al486Fig. 5. Chromoendoscopy facilitates visualization of NP-CRN. (A) The lesion was difficult
to appreciate with high-definition white-light endoscopy. A possible flat lesion was
noted retrospectively, as shown by the white arrowheads. (B) The patient presented for
follow-up 6 months later. A possible superficial elevated lesion was noted (blue arrow-
heads). (C) After application of dilute indigo carmine, the lesion and its borders were easily
detected.
Fig. 6. NP-CRN are relatively common in patients with long-standing ulcerative colitis.
Jaramillo and colleagues studied the yield of performing chromoendoscopy in patients
with extensive and long-standing ulcerative colitis, and found that most neoplasms
were flat. The detection of these superficial elevated, flat, or depressed neoplasms,
however, poses a special challenge because the background mucosa is often scarred
or inflamed.3 HGD, high-grade dysplasia; LGD, low-grade dysplasia; UC, ulcerative
colitis.
Atlas of Flat Lesions in IBD 487Fig. 7. Most colorectal neoplasms in colitic IBD are believed to be visible. A lesion might
be considered an “invisible” neoplasm because it was not recognized during the exami-
nation.4 The lesion shown in (A), despite being photographed en face, was not recognized
as a superficial elevated lesion with an ulcer. The endoscopist missed the lesion again dur-
ing a repeat surveillance colonoscopy 5 months later, which was performed to survey a
pedunculated polyp resection site. The patient, who has long-standing Crohn’s colitis,
presented to the authors 14 months later for surveillance colonoscopy. A similar-
appearing lesion was easily detected using chromoendoscopy (B). Understanding the
appearance of the NP-CRN and the signs of its presence are critical to performing an effi-
cacious colonoscopy.
Fig. 8. Understanding the techniques useful to visualize NP-CRN is important, as NP-CRN
in patients with colitic IBD can be very difficult to detect. This patient with Crohn’s colitis
had endoscopic mucosal resection (EMR) of a superficial elevated NP-CRN. The pathology
of the lesion showed low-grade dysplasia (LGD). However, the biopsies of the surrounding
mucosa also showed LGD. Thus, he was referred for further evaluation. In (A), a slightly
more reddish mucosa was seen (open arrows). Chromoendoscopy with indigo carmine
was used to delineate the border of the lesion (B). The lesion had a distinct border. It
was completely endoscopically resected and found to be LGD. Note that a distal attach-
ment cap was required to push the fold (double solid arrows) to examine the area proximal
to the fold.5
Fig. 9. Understanding the nomenclature of superficial neoplasms is important. The term superficial is used when the tumor is either noninvasive
appearing or small. Superficial includes noncancer neoplasms, and mucosal and submucosal invasive cancers. A subset of superficial cancers
that appear to have a significant invasion into the submucosa is calledmassive submucosal invasive cancer. Matsuda and colleagues suggested
that the presence of redness, firm consistency, expansion, and deepdepression are important findings of deeply submucosal invasive cancer.6 In
the upper image, the neoplastic lesion appeared benign and limited to the mucosa. It has none of the findings of deeply submucosal invasion. In
the lower image, the lesion was large, and invaded deeply into the wall. The lesion was red, firm appearing, full, and had deep depression. The
lesion in the upper image may be removable by endoscopy, whereas surgery would be required for the lesion in the lower image.
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Fig. 10. Themajor variants of superficial neoplastic lesions in the colon and rectum. Superficial colorectal neoplasms in patients with IBD
can be described.7,8 Lesions are classified as protruding (polypoid) and nonprotruding (nonpolypoid). Polypoid neoplasms may be
further divided into pedunculated (0-Ip) or sessile (0-Is). Nonpolypoid lesions can be divided into slightly elevated/table top (IIa),
depressed (IIc), or completely flat (IIb). An international group of IBD experts, endoscopists, pathologists, andmethodologists who gath-
ered in San Francisco inMarch 2014 (SCENICConsensus) suggested that the current classifications for IBDpatients should also include:
(1) description of an ulcer, if present, within the lesion; and (2) description of the border of the lesion, especially if it cannot be recognized.9
A
tla
s
o
f
Fla
t
Le
sio
n
s
in
IB
D
4
8
9
Soetikno et al490Fig. 11. The presence of an ulcer within a lesion needs to be characterized. A 4-cm super-
ficial elevated neoplasm in a patient with long-standing Crohn’s colitis with a 7-mm ulcer is
shown. The ulcer appeared benign; its edge was not full and its base did not appear deep or
nodular. The patient elected to have a slightly delayed endoscopic resection, rather than an
immediate surgery. He was treated with a short course (2 months) of oral steroids. The ulcer
resolved following escalation of medical therapy, and the circumscribed superficial elevated
lesion was treated with endoscopic resection. The pathology indicated LGD. The presence
of an ulcer within a lesion, however, may indicate carcinomatous degeneration.
Fig. 12. The absence of the border of the lesion needs to be characterized. This ill-defined
nodular, friable, irregular surface was seen in the rectum during surveillance examination.
Even following the application of chromoendoscopy, the border remained unable to be
visualized. Such a lesion is not amenable to endoscopic resection, and targeted biopsy
should be performed. A tattoo of the area for marking was made, and the patient was
referred for surgical evaluation.
Atlas of Flat Lesions in IBD 491SIGNS OF NONPOLYPOID COLORECTAL NEOPLASMS IN IBD
Fig. 13. Signs of NP-CRN in colitic IBD. The detection of flat and depressed neoplasms in
colitic IBD, unlike the detection of polypoid neoplasms, relies primarily on the recognition of
subtle changes in themucosa. The subtle findings require constant awareness by the endo-
scopist for areas that appear to be slightly different than the background in color, pattern, or
level. (A) Nonpolypoid lesions typically have a slightly elevated appearance that can often
be recognized by a deformity on the colon wall (arrows). (B) Occasionally there may be
spontaneous hemorrhage on the surface. The surface may be friable. (C) Obscure vascular
pattern or (D) increased erythema (within circle) may suggest a lesion is present, in that
these lesions may disturb the mucosal vascular network. The surface pattern may show
(E) villous features or (F) irregular nodularity (arrow).
Fig. 14. Interruption of the innominate grooves can alert the endoscopist to the presence of
NP-CRN. Innominate grooves, on histology, are mucosal areas where several crypts open
into one central crypt. (A) On endoscopy, they are visible in normal colonic mucosa and
nonneoplastic lesions (arrows), whereas they are interrupted in neoplastic lesions. (B)
These areas can be better observed following the application of dye, such as indigo
carmine, as the dye pools into the grooves and makes them appear as blue lines (arrows).
Fig. 15. (A, B) Wall deformity is another sign of the presence of NP-CRN. The expected natural curve of the fold is shown in A (dotted
line). In this case, the wall was deformed. A large superficial flat neoplasm was the cause of this deformity.
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Fig. 16. General to detailed visualization of a superficial elevated neoplasm and its imaging documentation. Examination of a lesion to under-
stand the significance of its detail is a fluid stepwise process. For example, (A) on detection, the lesion is first viewed in a long view, to un-
derstand and evaluate its relative size, shape, and location. The lesion is then examined with varying expansion of the colon. Increasing (B) or
decreasing (C) air insufflation may help improve visualization of a flat or depressed lesion. (D) Closer view permits detailed examination of the
vessel and surface pattern. (E, F) Application of indigo carmine dye further enhances the borders of the lesion and the details of the
morphology and surface pattern.
PHOTODOCUMENTATION
A
tla
s
o
f
Fla
t
Le
sio
n
s
in
IB
D
4
9
3
Fig. 17. General to detailed visualization of a flat neoplasm and its imaging documen-
tation, illustrating the use of a translucent distal attachment device (cap) in the detailed
view and understanding of the lesion. Documentation of the lesion is best performed by
taking an overview (long-shot) picture, before close-up pictures are taken (A, B, C). In
(A), the lesion is inspected using high definition white light. In (B), narrow-band imaging
(NBI) was used to visualize the surface and microvessel patterns. In (C), indigo carmine
was used to determine the margin of the lesion. Pit-pattern characterization of the
lesion using either NBI or indigo carmine is generally not useful. Detailed imaging of
the lesion is critical for its complete resection. (D) A circumferential cut was performed
494Fig. 18. (A–C) White-out (halation) can impair adequate viewing and interpretation. There is
a blurred effect around the edges of the area highlighted caused by reflection and scat-
tering of light.
to isolate the lesion before its snaring.
Atlas of Flat Lesions in IBD 495Fig. 19. Appropriate setting of the iris is important. The iris function on endoscope pro-
cessors adjusts the distribution of light, and is generally sufficient to adjust brightness.
 Auto: The brightness is adjusted based on the brightest part of the central part and
the average brightness of the periphery part.
 Peak: The brightness is adjusted based on the brightest part of the endoscopic image.
Fig. 20. Inadequate documentation and preparation, and inappropriate use of, image-
enhanced endoscopy. A picture is worth a thousand words, except when the picture is
not adequate. In this case, only close-up images were taken (A–F). In addition, surveillance
for IBD dysplasia must be performed in patients with inactive disease, with bowel prepara-
tion of adequate quality and the appropriate imaging and tools. A surveillance colonoscopy
with random biopsies was performed with the aid of NBI in this 41-year-old patient with
long-standing Crohn’s colitis and primary sclerosing cholangitis (A, B). Importantly the
images show severe disease inactivity and inadequate bowel preparation. NBI, which
has not been shown to provide any benefit for detection of dysplasia when compared
with white light or chromoendoscopy, was used (C, D). Random biopsies were performed,
which showed severe chronic active colitis with focal LGD in the right colon, and moderate
chronic active colitis in the transverse and left colon. No biopsies were taken of the rectum.
One year later, a repeat colonoscopy was performed in the setting of less active disease
using chromoendoscopy with targeted biopsy. Targeted biopsy showed (E) an invasive
low-grade adenocarcinoma in the rectum and (F) a nonpolypoid dysplastic lesion in the
hepatic flexure.
Soetikno et al496GENERAL PRINCIPLES
Fig. 21. High-definition white-light imaging is superior to standard-definition white-light
imaging for surveillance of dysplasia in the detection of dysplasia and/or CRC in patients
with colitic IBD. Surveillance using high-definition colonoscopy detected significantly
more patients with dysplasia (prevalence ratio 2.3, 95% confidence interval [CI] 1.03–
5.11) and detected significantly more endoscopically visible dysplasia (risk ratio 3.4,
95% CI 1.3–8.9).10Chromoendoscopy with targeted biopsy leads to increased efficacy
compared to white light colonoscopy
 Leads to 7% (95% CI: 3.3 to 10.3%) increase in the detection of dysplasia/patient
 NNT to find another patient with at least one dysplasia: 14.3 (range 9.7 to 30.3)
 Likelihood to find any dysplasia: Odds ratio: 8.9 (95% CI: 3.4 to 23)
 Likelihood to find flat dysplasia: Odds ratio 5.2 (95% CI: 1.7 to 15.9)Box. 1. Chromoendoscopy with targeted biopsy leads to increased efficacy of surveillance.
In a meta-analysis of 6 clinical trials comparing chromoendoscopy with white-light endos-
copy, chromoendoscopy detected additional dysplasia in 7% of patients in comparison
with white-light endoscopy. The number needed to treat (NNT) to find another patient
with at least 1 dysplasia was 14. Chromoendoscopy with targeted biopsy increased the
likelihood of detecting any dysplasia by 9 times when compared with white light, and the
likelihood of detecting nonpolypoid dysplasia was 5 times higher. (Data from Soetikno R,
Subramanian V, Kaltenbach T, et al. The detection of nonpolypoid (flat and depressed)
colorectal neoplasms in patients with inflammatory bowel disease. Gastroenterology
2013;144(7):1349–52.)
Atlas of Flat Lesions in IBD 497Fig. 22. Standard definition chromoendoscopy is superior to standard definition white
light imaging in the detection of dysplasia and/or CRC in patients with colitic IBD. A
meta-analysis of 8 studies that included a total of 785 patients with IBD, 82 (10.4%)
of whom were later found to have dysplasia and 7, cancer (0.89%), showed superior-
ity in the use of chromoendoscopy (left) when compared with white light (right):
1. Detected significantly more patients with dysplasia: incremental yield 6%, 95% CI 2.8%
to 9.2%
2. Detected significantly more patients with endoscopically visible dysplasia: incremental
yield 7%, 95% CI 3.0% to 10.0%
3. Detected significantly more dysplasia: incremental yield 15%, 95% CI 5.0% to
24.0%.
Fig. 23. High definition with indigo carmine is superior to high definition white light in the
detection of dysplasia and/or colorectal cancer in patients with colitic IBD.
1. Detected significantly more patients with dysplasia, 21.3% (16/75) versus 9.3% (7/75),
incremental yield 12% (P 5 .007)
2. Detected significantly more endoscopically visible dysplasia, 100% (22/22) versus
45.4% (10/22), incremental yield 16% (P 5 .004)
3. Detected significantly more patients with nonpolypoid dysplastic lesions, 9.3% versus
1.3%, incremental yield 8% (P 5 .011).11
Soetikno et al498Fig. 24. High definition NBI is not superior to high-definition white light in the detection of
dysplasia in IBD patients. Two studies on the performance of surveillance colonoscopy
with a high definition colonoscope were performed to compare NBI with white light. A total
of 160 patients with IBD, 21 (13.1%) of whom were later found to have dysplasia and none,
cancer, were studied. The use of NBI, compared with white light, did not lead to significant
differences in the number of patients who were found to have any dysplasia. In fact, the use
of NBI led to decreased detection of dysplastic lesions.12,13 The first generation of NBI was
used in the studies and in this image. Note that the use of NBI caused the image to become
quite dark. On biopsy of the depressed area (arrows), high-grade dysplasia (HGD) was
found.Fig. 25. A large, superficial, elevated lesion was imaged using the latest generation of NBI.
The image was still somewhat dark.
Fig. 26. High-definition NBI is not superior to high-definition chromoendoscopy. There has been interest to use NBI in lieu of chromoendo-
scopy in IBD surveillance. Four studies on surveillance colonoscopy with high-definition colonoscopy have been performed to compare chro-
moendoscopy with NBI. NBI was not shown to be advantageous. In fact, surveillance with chromoendoscopy showed a 6% (95% CI 1.4%
to 14.2%) higher yield in the detection of patients with dysplasia in comparison with NBI, although the difference did not reach statistical
significance.
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Soetikno et al500TECHNIQUE OF CHROMOENDOSCOPY WITH TARGETED
BIOPSY
Fig. 27. The disease should be in remission before surveillance is undertaken. Active colitis
causes changes in mucosal color, texture, and vascularity that can be extremely difficult to
distinguish from nonpolypoid neoplasia. Furthermore, mucosal inflammation and regener-
ation can cause cytologic changes that can mimic dysplasia.
Fig. 28. Wash residue during insertion. When performing a chromoendoscopy with tar-
geted biopsy, irrigate the colon of debris with water while intubating to the cecum. Any
remaining residue should be meticulously washed and suctioned before the application
of chromoendoscopy. Chromoendoscopy begins once one reaches the cecum and the
colonoscope is withdrawn. Performing chromoendoscopy when the colon is dirty is very
difficult: when the blue dye mixes with the bilious stool, it turns green.
Atlas of Flat Lesions in IBD 501Fig. 29. Target biopsies of abnormal or suspicious areas. Most dysplasia is visible and,
thus, biopsies should be targeted. Rather than taking random biopsies, the endoscopist
compares the color, pattern of the pits, glands, and, when visible, the microvessels to
the background mucosa to target biopsies to abnormal-appearing areas.
Fig. 30. Evaluate lesions thoroughly. A biopsy forceps was used to investigate part of the
large, superficial, elevated lesion that lay behind the fold. The colon was slightly deflated as
the forceps was used to expose the proximal side of the lesion.
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Fig. 31. An algorithm to detect, diagnose, and treat colorectal neoplasms in patients with colitic IBD using chromoendoscopy and targeted
biopsy. (From Soetikno R, Subramanian V, Kaltenbach T, et al. The detection of nonpolypoid (flat and depressed) colorectal neoplasms in
patients with inflammatory bowel disease. Gastroenterology 2013;144(7):1349–52; with permission.)
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Soetikno et al504Fig. 32. Using high-definition instruments, image-enhanced endoscopy (IEE) is performed
with indigo carmine using 3 different concentrations. Varying the concentration is impor-
tant, depending on the indication. For example, if the solution is too concentrated when
spraying the entire colon, it can make the colon dark and impair inspection. The corollary
is when selectively spraying indigo carmine on a lesion for detailed inspection the solution
is too weak, in which case it does not enhance visualization or contrast. When resecting a
lesion, the authors perform submucosal injection using a dilution of indigo carmine and
saline (10 drops of indigo carmine with 100 mL of normal saline). (From Soetikno R,
Subramanian V, Kaltenbach T, et al. The detection of nonpolypoid (flat and depressed)
colorectal neoplasms in patients with inflammatory bowel disease. Gastroenterology
2013;144(7):1349–52; with permission.)
Fig. 33.Mixing of indigo carmine for chromoendoscopy throughout the colon. The forward
wash jet solution is made combining 2 ampules of 5 mL of 0.8% indigo carmine with 250mL
of water.
Atlas of Flat Lesions in IBD 505Fig. 34. Equipment for detection of NP-CRN in IBD. After complete insertion of the co-
lonoscope, examination with chromoendoscopy begins in the cecum and proceeds
methodically. During withdrawal, each segment is sprayed and carefully inspected. In-
digo carmine is spray diluted (w0.03%) through the forward wash jet. For optimal appli-
cation and efficiency, the foot wash pump is used for spraying, and the spray is
targeted to the antigravity wall of the colon. Any excess dye that pools is suctioned
so that a thin layer remains and the mucosa is not obscured by blue pools. The lumen
is expanded and collapsed with air insufflation and suctioning during chromoendo-
scopy examination.
Fig. 35. Detailed viewing. When lesions or possible lesions are identified, more concen-
trated indigo carmine (0.13%, 5 mL ampule of indigo carmine with 25 mL water) is
applied with a syringe via the biopsy channel to better delineate the lesion extent and
the mucosal detail.
Fig. 36. Lesion identification technique of chromoendoscopy. (A) Using a high definition colonoscope, dilute indigo carmine is applied using
the forward wash jet. (B) When lesions are identified, more concentrated indigo carmine is applied via the biopsy channel to better delineate
the lesion extent and the mucosal detail. Targeted biopsies are then taken of the lesion. Biopsies are also taken around the lesion to exclude
flat, invisible dysplasia, which would render it endoscopically unresectable.
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507Atlas of Flat Lesions in IBDFig. 37. Current pit-pattern classification of colorectal neoplasms may not be applicable in
colitic IBD. The analysis of pit patterns of possible NP-CRN in patients with colitic IBD is
difficult for many reasons. Inflammatory activity may mimic neoplasia. The regenerative
hyperplastic villous mucosa is difficult to distinguish from neoplastic pit patterns. (From
Tanaka S, Kaltenbach T, Chayama K, et al. High magnification colonoscopy (with videos).
Gastrointest Endosc 2006;64:604–13; with permission.)
Soetikno et al508Fig. 38. Inflammatory polyp. High definition imaging enables the endoscopist to discrimi-
nate between inflammatory polyps, serrated lesions, and lesions with LGD, HGD, or inva-
sive cancer. It is unnecessary to biopsy or remove obvious inflammatory polyps or lesions,
such as seen here.
Fig. 39. Biopsies of all suspicious lesions are recommended to exclude dysplasia. This
35-year-old man with an indeterminate colitis had a 1-cm inflammatory-appearing
polypoid lesion within a colitic area. Biopsies excluded dysplasia and confirmed chronic
inflammation.
Atlas of Flat Lesions in IBD 509Fig. 40. Inflammatory polyps. In addition to enhancing the border, chromoendoscopy
makes it easier to examine the mucosal surface of lesions and facilitates the recognition
of inflammatory patterns. Below, a few examples of hyperplastic polyps and sessile
serrated adenomas/ polyps are presented.
Fig. 41. Hyperplastic polyp.
Fig. 42. Sessile serrated adenoma/polyp.
Fig. 43. Sessile serrated adenoma/polyp.
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Fig. 44. Depressed neoplasm. Visualization of the depressed morphology required the application of chromoendoscopy. The depressed
center of this nonpolypoid (0-IIc) lesion with LGD can only be shown by spraying indigo carmine to show it pooling in the depressed part.
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Soetikno et al512Fig. 45. See above (Fig. 44). Visualization of the depressed morphology required the appli-
cation of chromoendoscopy. It is important to understand that the depressed area likely
contains the most advanced histology. Thus, both biopsy can be targeted and removal
can be optimized.
Fig. 46. (A–D) Polypoid neoplasms can be endoscopically resected. Whenever possible,
lesions less than 2 cm in size should be resected in one piece (ie, en bloc) using EMR.
The use of chromoendoscopy can facilitate delineation of the neoplastic borders and
ensure complete resection. Following resection, the mucosa around the site should be
biopsied to exclude the presence of invisible dysplasia.
513Atlas of Flat Lesions in IBDFig. 47. Dynamic injection can be useful in IBD. Sessile and non-polypoid colorectal lesions
in patients with IBD may be best cut after injection. Using the dynamic injection technique
the injection is directed into the lumen, to mold the fluid bleb formation. Using slight upward
tip deflection, the lumen is suctioned and the needle catheter nominally pulled back while
directing the injection into the lumen. In this case, the lesion lifted nicely to form a large bleb.
EMR is performed, placing a snare at the normal surrounding edges for en bloc resection. In
nonlifting cases, because of underlying fibrosis endoscopic submucosal dissection may be
necessary for complete resection.14Fig. 48. Ensuring complete resection. Close endoscopic visualization of the surroundings
of the resection area to ensure complete resection cannot be overemphasized. In this
case, indigo carmine is applied to delineate its borders. EMR is performed, showing sig-
nificant fibrosis. However, close inspection of the defect borders shows residual lesion
(arrows). Repeat snare of the site is immediately performed to achieve complete resec-
tion. Argon plasma coagulation is then used to coagulate the base and edges of the
resection.
Fig. 49. Evaluation of the surroundings is critical. Following resection, close inspection of
the resection defect borders should be performed, and any residual neoplasia removed.
In addition, the mucosa around the site should be biopsied to exclude the presence of
invisible dysplasia.
514Fig. 50. Multiple nonpolypoid neoplasms can be endoscopically resected during a single
procedure. A 62-year-old patient with long-standing Crohn’s colitis underwent surveillance
colonoscopy that showed multiple neoplasms distributed throughout the colon. (1A to 1C)
and (2A to 2E) illustrate details of diagnosis and resection of the lesions. Chromoendoscopy
using indigo carmine 0.4% was used for delineation of the borders and examination of the
epithelial surface. En bloc EMR resections were performed (1C, 2E). Histopathology
showed LGD within chronic colitis.
Fig. 51. Endoscopic resection in patients with Crohn’s or ulcerative colitis can be ve
fibrosis. Multiple biopsies for removal of such lesions must be avoided. EMR is usua
the high level of difficulty and risk in endoscopic resection of IBD lesions. Endoscopic
resection in some cases, such as shown here. Following injection of the submucosa,
a circumferential incision around the lesion border and dissect the fibrosis submuco
one piece.ry difficult because of underlying thickened mucosa and
lly the most appropriate endoscopic therapy, noting still
submucosal dissection may be necessary for complete
there is minimal lifting. Thus, a dual knife is used to make
sally, after which a snare is used to remove the lesion in
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Soetikno et al516Fig. 52. Severe fibrosis in Crohn’s or ulcerative colitis can make endoscopic removal
technically difficult. The marked fibrosis of the submucosa of a dysplastic lesion, as shown
here during endoscopic submucosal dissection, can lead to the lesion not rising up during
endoscopic resection.
Fig. 53. EMR in the setting of submucosal fibrosis. Resection is this setting is exceedingly
difficult and risky. (A) The lesion did not lift adequately despite a large amount of injection
medium. (B) The lesion could not be captured by a snare. (C) The cuts were small. (D) The
underlying fibrosis was exposed.
Fig. 54. A lesion should be examined closely to facilitate assessment of its amenability to curative endoscopic resection. On closer inspection, this
sessile lesion was considered to have features suspicious for invasive malignancy; that is, the center of the lesion is depressed and the surface is
amorphous with loss of mucosal detail. Hence, decisions pertaining to endoscopic versus surgical resection were deferred pending biopsy results.
Biopsies should be targeted to the most concerning area of the lesion, as shown here (arrow), which confirmed invasive cancer. Surgical resection
demonstrated a T1, N0 lesion. (Images courtesy of Professor Shinji Tanaka, Hiroshima University.)
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Soetikno et al518LIMITATIONS OF CHROMOENDOSCOPY
Fig. 55. Random biopsy is still indicated when a large number of pseudopolyps are pre-
sent. The presence of a large number of postinflammatory polyps may complicate
surveillance colonoscopy with chromoendoscopy and targeted biopsy. It is difficult to
examine the pseudopolyps and the underlying mucosa when the lumen is filled with
the polyps. In such cases, random biopsies are indicated to maximize dysplasia
detection.15
Fig. 56. Dysplasia in the setting of large pseudopolyps. In addition to random biopsy, chro-
moendoscopy was used in this case. Note the appearance of a superficial elevated lesion
(white arrows), which on biopsy proved to be HGD, surrounding the polypoid lesion (double
black arrows).
Fig. 57. Examination of a stricture can be difficult because of poor lighting within it, which occurred because of the narrowed lumen. A 79-year-old
patient with long-standing ulcerative colitis presented for reevaluation of a stricture in the sigmoid colon. The patient was diagnosed to have the stric-
ture 6 years earlier, but he declined surgery. Over the years, he underwent multiple colonoscopies with biopsies that did not show malignancy (A). The
appearance of a cancer within the stricture was finally seen when the stricture was well illuminated (arrows, B). The lumen was kept distended using
water infusion. On close-up, the lesion appeared neoplastic (C). The center of the lesion (D) was suspicious for invasive cancer. Biopsy showed inva-
sive adenocarcinoma. Patients with ulcerative colitis are recommended to have surgery when a colonic stricture is found.
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